The campaign for Soolantra utilises characterisation very effectively to depict the efficacy of the treatment and its ability to eliminate the symptoms of the chronic skin disorder – Rosacea once and for all.
Galderma, a specialist on skin medical solutions developed a potent topical treatment, 'Soolantra' for Rosacea, a common chronic inflammatory skin disorder which affects an estimated 40 million people worldwide. In the past ten years, dermatological research failed to provide an effective treatment whereby causing exasperation in patients and doctors alike.
In this scenario, the challenge was to showcase Soolantra in a new light. The differentiating factor of this topical treatment was its efficacy when compared to other treatments available. But, with so many treatments falsely advertising themselves to be effective, the campaign had to be innovative and make people believe that this topical treatment is distinct among the many available in the market.
The concept of the campaign was based on the story of good versus evil or strong versus weak. With Soolantra as the mighty hero overpowering the evil Rosacea that has plagued its victims since a decade, this universal story captured the true essence of the product while being relatable to the mass audience. To make a large impact and gain maximum exposure, the campaign was showcased in personal and non-personal channels. The animated endorsement appeared on iPads of representatives during sales calls, banners, physician's website and professional e-mails. Along with print materials such as posters, flash cards, and brochures, even high-profile tactics at the American Academy of Dermatology convention was held.
By showcasing Soolantra as the powerful topical ascending above all other agents to overpower the papules appearing on the face of the sufferers, this groundbreaking endorsement has achieved to convey its benefits and create awareness about its presence in the market. Receiving an extremely positive feedback overall, there has been a steady increase in total prescriptions since the launch of the campaign.